Mesa Laboratories, Inc. (MLAB) vs Sana Biotechnology, Inc. (SANA)
A side-by-side comparison of Mesa Laboratories, Inc. and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MLAB
Mesa Laboratories, Inc.
$136.38HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SANA
Sana Biotechnology, Inc.
$2.78HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — MLAB vs SANA
growth of $100 · dividends reinvested · last 6yMLAB -47.4% (-10.1%/yr)SANA -91.8% (-34.1%/yr)MLAB compounded faster over this window
Log scale — wide-divergence pair
MLAB SANA
MLAB vs SANA: by the numbers
- •SANA is the larger company ($772M vs $763M market cap).
- •MLAB is profitable (1.92% net margin) while SANA runs a net loss (0.00%).
- •MLAB pays a dividend (0.45% yield), while SANA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MLAB | SANA |
|---|---|---|
| P/E ratio | 162.35 | N/A |
| PEG ratio | 11.95 | N/A |
| P/S ratio | 3.06 | N/A |
| P/B ratio | 4.04 | 5.00 |
| EV / EBITDA | 18.35 | N/A |
| FCF yield | 6.93% | N/A |
Profitability
| Metric | MLAB | SANA |
|---|---|---|
| Gross margin | 65.99% | 0.00% |
| Operating margin | 9.00% | 0.00% |
| Net margin | 1.92% | 0.00% |
| ROE | 2.54% | -137.04% |
| ROIC | 3.29% | -67.58% |
Dividends
| Metric | MLAB | SANA |
|---|---|---|
| Dividend yield | 0.45% | N/A |
| Payout ratio | 76.19% | N/A |
Growth (annualized)
| Metric | MLAB | SANA |
|---|---|---|
| Revenue CAGR (5Y) | 12.45% | N/A |
| EPS CAGR (5Y) | 13.08% | N/A |
| FCF CAGR (5Y) | 4.63% | N/A |
| Total return CAGR (5Y) | -13.52% | -32.33% |
Frequently asked
- Does MLAB or SANA pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while SANA has no payments in the available dividend history.
- Is MLAB or SANA more profitable?
- MLAB runs the higher net margin — MLAB at 1.92% versus SANA at 0.00%.
- How have MLAB and SANA total returns compared?
- Over the past 5 years, MLAB delivered -13.52% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldMesa Laboratories ROESana Biotechnology ROEMesa Laboratories operating marginSana Biotechnology operating marginMesa Laboratories revenue growthSana Biotechnology revenue growthMesa Laboratories free cash flowSana Biotechnology free cash flow
Mesa Laboratories & Sana Biotechnology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.